Paul A. Lyons, Ph What is the difference between viagra and cialis? .D., Tim F. Rayner, Ph.D., Sapna Trivedi, M.R.C.P., M.Phil., Julia U. Holle, M.D., Ph.D., Richard A. Watts, D.M., F.R.C.P., David R.W. Jayne, M.D., F.R.C.P., Bo Baslund, M.D., Ph.D., Paul Brenchley, Ph.D., Annette Bruchfeld, M.D., Ph.D., Afzal N. Chaudhry, Ph.D., F.R.C.P., Jan Willem Cohen Tervaert, M.D., Ph.D., Panos Deloukas, Ph.D., Conleth Feighery, M.D., Wolfgang L. Gross, M.D., Ph.D., Loic Guillevin, M.D., Iva Gunnarsson, M.D., Ph.D., Lorraine Harper, M.R.C.P., Ph.D.D., Tag A.
Statistical tests were two-sided, and P values of less than 0.05 were considered to indicate statistical significance. We present risk estimates for women and men separately. No). Furthermore, risk estimates for loss of life from cancers were adjusted for history of cancer in a first-level relative . For women, position with respect to postmenopausal hormone therapy was included in multivariate models also. Less than 5 percent of the cohort lacked any single covariate; for each covariate, an indicator was included by us for lacking data in the regression models, if required.